Healthcare ❯ Pharmaceuticals ❯ Drug Development

Obesity Treatment

GLP-1 Drugs MariTide AMG 786 Small Molecule Drugs Zepbound Orforglipron GLP-1 Inhibitors Clinical Trials Petrelintide Retatrutide

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

Underwhelming efficacy has investors questioning differentiation, dose response, Phase 3 upside.

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs